首页> 美国卫生研究院文献>other >Functional defect in regulatory T cells in myasthenia gravis
【2h】

Functional defect in regulatory T cells in myasthenia gravis

机译:岩体肌无力调节性T细胞的功能缺陷

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Forkhead box P3 (FOXP3)+ is a transcription factor necessary for the function of regulatory T cells (Treg cells). Treg cells maintain immune homeostasis and self-tolerance, and play an important role in the prevention of autoimmune disease. Here, we discuss the role of Treg cells in the pathogenesis of myasthenia gravis (MG) and review evidence indicating that a significant defect in Treg cell in vitro suppressive function exists in MG patients, without an alteration in circulating frequency. This functional defect is associated with a reduced expression of key functional molecules such as FOXP3 on isolated Treg cells and appears to be more pronounced in immunosuppression-naive MG patients. In vitro administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) enhanced the suppressive function of Treg cells and up-regulated FOXP3 expression. These findings indicate a clinically relevant Treg cell–intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.
机译:前叉箱P3(FOXP3) + 是调节性T细胞(Treg细胞)功能所必需的转录因子。 Treg细胞保持免疫稳态和自我耐受性,并在预防自身免疫性疾病中发挥重要作用。在这里,我们讨论了Treg细胞在重症肌无力(MG)发病机理中的作用,并综述了表明MG患者存在Treg细胞体外抑制功能的重大缺陷,而没有改变循环频率的证据。此功能缺陷与分离的Treg细胞上关键功能分子(例如FOXP3)的表达降低有关,并且在未接受免疫抑制的MG患者中似乎更为明显。粒细胞巨噬细胞集落刺激因子(GM-CSF)的体外给药增强了Treg细胞的抑制功能,并上调了FOXP3表达。这些发现表明MG的免疫调节存在与临床相关的Treg细胞内在缺陷,这可能揭示了新的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号